Director of HEOR
Ipsen Pharmaceuticals
Strategic and innovative leadership within health economics and outcomes research (HEOR), comparative effectiveness, market access, and healthcare informatics. Known as a subject matter expert developing strong relationships with payer, health care provider, and academic audiences as well as key internal stakeholders. Diversified life science industry experience includes managerial, clinical, and marketing expertise gained from professional practice and real-world evidence development.